Genesis®200 is the world’s first quantitative, fully-automated, stain-free, multi-organ, 2D & 3D multiphoton imaging system, designed to aid in preclinical studies as well as clinical trials for the drug development of Nonalcoholic Steatohepatitis (NASH).

Home page of this offering   provided by HistoIndex